First‐line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate‐to‐severe bullous pemphigoid

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|173|1|302-304

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.173, Iss.1, 2015-07, pp. : 302-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 261-269

Karger

Access to resources Recommend Favorite

Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 17-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bullous Pemphigoid in an HB Virus Carrier: Interaction between Corticosteroids and HB Virus

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 3, 1997-03 ,pp. : 179-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 240-249

John Wiley & Sons Inc

Access to resources Recommend Favorite